BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10194070)

  • 1. Host modulation as a therapeutic strategy in the treatment of periodontal disease.
    Kornman KS
    Clin Infect Dis; 1999 Mar; 28(3):520-6. PubMed ID: 10194070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of periodontitis: role of cytokines in host response.
    Deo V; Bhongade ML
    Dent Today; 2010 Sep; 29(9):60-2, 64-6; quiz 68-9. PubMed ID: 20973418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the host response in the treatment of periodontitis.
    Golub LM; Ryan ME; Williams RC
    Dent Today; 1998 Oct; 17(10):102-6, 108-9. PubMed ID: 10752438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review.
    Reddy MS; Geurs NC; Gunsolley JC
    Ann Periodontol; 2003 Dec; 8(1):12-37. PubMed ID: 14971246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection.
    Trombone AP; Ferreira SB; Raimundo FM; de Moura KC; Avila-Campos MJ; Silva JS; Campanelli AP; De Franco M; Garlet GP
    J Periodontal Res; 2009 Aug; 44(4):443-51. PubMed ID: 18973535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications for host modulatory therapy.
    Ryan ME
    Compend Contin Educ Dent; 2002 Nov; 23(11A):1071-6, 1079-80, 1082. PubMed ID: 12789987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host response modulation in the management of periodontal diseases.
    Salvi GE; Lang NP
    J Clin Periodontol; 2005; 32 Suppl 6():108-29. PubMed ID: 16128833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using host response modifiers in the treatment of periodontal disease.
    Novak MJ; Donley TG
    Pract Proced Aesthet Dent; 2002; 14(9):suppl 3-10; quiz 11. PubMed ID: 12685424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-mediated resolution of inflammation in periodontal diseases.
    Kantarci A; Hasturk H; Van Dyke TE
    Periodontol 2000; 2006; 40():144-63. PubMed ID: 16398691
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
    Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
    Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host modulation with tetracyclines and their chemically modified analogues.
    Golub LM; Suomalainen K; Sorsa T
    Curr Opin Dent; 1992 Mar; 2():80-90. PubMed ID: 1325849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of baicalin on ligature-induced periodontitis in rats.
    Cai X; Li C; Du G; Cao Z
    J Periodontal Res; 2008 Feb; 43(1):14-21. PubMed ID: 18230102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of Tacrolimus, a calcineurin inhibitor, in experimental periodontitis in rats.
    Guimarães MR; Nassar PO; Andia DC; Nassar CA; Spolidorio DM; Rossa C; Spolidorio LC
    Arch Oral Biol; 2007 Sep; 52(9):882-8. PubMed ID: 17367747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy.
    McCauley LK; Nohutcu RM
    J Periodontol; 2002 Nov; 73(11):1377-91. PubMed ID: 12479643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation.
    Sorsa T; Tjäderhane L; Konttinen YT; Lauhio A; Salo T; Lee HM; Golub LM; Brown DL; Mäntylä P
    Ann Med; 2006; 38(5):306-21. PubMed ID: 16938801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of methotrexate on alveolar bone loss in experimental periodontitis in Wistar rats.
    Verzeletti GN; Gaio EJ; Rösing CK
    Acta Odontol Scand; 2007 Nov; 65(6):348-51. PubMed ID: 18071956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for managing periodontal inflammation.
    Schonfeld SE
    J Calif Dent Assoc; 2010 Apr; 38(4):272-83. PubMed ID: 20509367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue destruction in periodontitis: bacteria or cytokines fault?
    Bascones A; Noronha S; Gómez M; Mota P; Gónzalez Moles MA; Villarroel Dorrego M
    Quintessence Int; 2005 Apr; 36(4):299-306. PubMed ID: 15835427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel host response therapeutic approaches to treat periodontal diseases.
    Kirkwood KL; Cirelli JA; Rogers JE; Giannobile WV
    Periodontol 2000; 2007; 43():294-315. PubMed ID: 17214846
    [No Abstract]   [Full Text] [Related]  

  • 20. Lippia sidoides and Myracrodruon urundeuva gel prevents alveolar bone resorption in experimental periodontitis in rats.
    Botelho MA; Rao VS; Carvalho CB; Bezerra-Filho JG; Fonseca SG; Vale ML; Montenegro D; Cunha F; Ribeiro RA; Brito GA
    J Ethnopharmacol; 2007 Sep; 113(3):471-8. PubMed ID: 17714897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.